Health officials are alerting the public to a newly detected COVID-19 strain, urging continued precautions and vaccinations ...

It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it ...

Add Yahoo as a preferred source to see more of our stories on Google. It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. Neal Browning, one of the first people to test the COVID-19 Moderna mRNA vaccine, has taken to social media six years ...

Six years after COVID-19 first reached New Zealand, the country is experiencing its ninth wave of infections. But the virus we are living with today behaves very differently from the one that caused ...

A key federal vaccine advisory panel has abandoned an attack on the covid-19 mRNA vaccines — a shift that comes as some Republicans warn that any more changes to vaccine policy could damage the party ...

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Just over two months into 2026, Moderna has weathered a number of regulatory and financial storms that could have proven catastrophic. Moderna, which was already financially struggling, announced ...

A patent dispute over technology key to messenger RNA Covid-19 vaccines is settling with Moderna agreeing to pay $950 million up front and potentially more than $1 billion later, a resolution that ...

Moderna MRNA.O has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences ROIV.O, and Arbutus Biopharma ABUS.O up to $2.25 billion to settle a long-running legal fight over the technology ...